Summary
To learn more about the preclinical phase of IDDM we observed for a median period of 46.5 months (range 0.5–69 months) a group of 57 siblings positive for ICA and/or IAA when first screened within 6 months of the diagnosis of the proband. Sequential blood samples and IVGTTs were obtained at intervals of 6–12 months. Seventeen siblings (29.8%) presented with IDDM during the observation period. The duration of the known preclinical period ranged from 0.5 to 51 months (median 29 months). The converters were younger than the other siblings (P<0.05) and had higher initial ICA levels (P<0.01). In addition they had a lower FPIR in the first IVGTT (P<0.001). On all subsequent tests the converters had higher ICA levels and a lower FPIR (P<0.05 or less), a lower glucose elimination rate from the third test onwards (P<0.01 or less) and higher IAA levels at 3 years (P<0.05). Some variation could be observed in the FPIR in the converters with an initial increase and subsequent decrease (P<0.05 for both). Their levels of complement-fixing ICA increased up to 18 months (P<0.05) and IAA levels up to 3 years (P<0.01). Those high risk siblings who progress to clinical IDDM are characterized by young age, strong and increasing signs of islet-cell specific autoimmunity, reduced insulin secreting capacity and emerging glucose intolerance. The present observations seem to be incompatible with the hypothesis of beta-cell destruction occurring at a constant, predictable rate.
Article PDF
Similar content being viewed by others
Abbreviations
- IDDM:
-
Insulin-dependent diabetes mellitus
- ICA:
-
islet cell antibodies
- IAA:
-
insulin antibodies
- IVGTT:
-
intravenous glucose tolerance test
- FPIR:
-
first phase insulin response
- JDF:
-
Juvenile Diabetes Foundation
References
Eisenbarth GS (1986) Type 1 diabetes: a chronic autoimmune disease. N Engl J Med 314:1360–1368
Bonifacio E, Bottazzo GF (1991) Immunology of IDDM (type 1 diabetes) — Entering the '90s. In: Alberti KGMM, Krall LP (eds) Diabetes annual/6. Elsevier, Amsterdam, pp 20–47
Bennett PH (1990) Epidemiology of diabetes mellitus. In: Rifkin H, Porte D Jr (eds) Diabetes mellitus, theory and practice. Elsevier, New York pp 357–377
Krolewski AS, Warram J, Rand LI, Kahn CR (1987) Epidemiologic approach to the etiology of type 1 diabetes and its complications. N Engl J Med 317:1390–1397
Reunanen A, Åkerblom HK, Käär M-L (1982) Prevalence and ten year (1970–79) incidence of insulin-dependent diabetes mellitus in children and adolescents in Finland. Acta Paediatr Scand 71: 893–899
Tuomilehto J, Lounamaa R, Tuomilehto-Wolf E et al. (1992) Epidemiology of childhood diabetes mellitus in Finland — background of a nationwide study of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 35:70–76
Srikanta S, Ganda OP, Rabizadeh A, Soeldner JS, Eisenbarth GS (1985) First-degree relatives of patients with type 1 diabetes mellitus: islet cell antibodies and abnormal insulin secretion. N Engl J Med 313:461–464
Ziegler R, Jackson RA, Ziegler AG, Eisenbarth GS (1990) Type 1 diabetes: polygenic inheritance, multiple autoantigens and “dual” parameter prediction. J Autoimmun 3 [Suppl 1]: 69–74
McCulloch DK, Klaff LJ, Kahn SE et al. (1990) Nonprogression of subclinical β-cell dysfunction among first-degree relatives of IDDM patients: 5-yr follow-up of the Seattle family study. Diabetes 39: 549–556
Bonifacio E, Bingley PJ, Shattock M et al. (1990) Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes. Lancet I:147–149
Riley WJ, Maclaren NK, Krischer J et al. (1990) A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes. N Engl J Med 323: 1167–1172
Olmos P, A'Hern R, Heaton DA et al. (1988) The significance of the concordance rate for type 1 (insulin-dependent) diabetes in identical twins. Diabetologia 31:747–750
WHO Study Group (1985) Diabetes mellitus. Technical Report Series 727. World Health Organisation, Geneva, pp 10–12
Bottazzo GF, Dean BM, Gorsuch AN, Cudworth AG, Doniach D (1980) Complement-fixing islet cell antibodies in type 1 diabetes: possible monitors of active beta-cell damage. Lancet I:668–672
Lernmark Å, Molenaar JL, van Beers WAM et al. (1991) The fourth international serum exchange workshop to standardize cytoplasmic islet cell antibodies. Diabetologia 34:534–535
Palmer JP, Asplin CM, Clemons P et al. (1983) Insulin antibodies in insulin-dependent diabetics before insulin treatment. Science 222:1337–1339
Hjelm M (1966) Enzymatic determination of hexoses in blood and urine. Scand J Clin Lab Invest 192 [Suppl]: 85–98
Herbert V, Lau KS, Gottlieb CW, Bleicher SJ (1965) Coated charcoal immunoassay of insulin. J Clin Endocrinol 25:1375–1384
Knip M, Ilonen J, Mustonen A, Åkerblom HK (1986) Evidence of an accelerated B-cell destruction in HLA Dw3/Dw4 heterozygotes with type 1 (insulin-dependent) diabetes. Diabetologia 29:347–351
Maclaren NK (1988) How, when and why to predict IDDM. Diabetes 37:1591–1594
Karjalainen J, Salmela P, Ilonen J, Surcel HM, Knip M (1989) A comparison of childhood and adult type 1 diabetes mellitus. N Engl J Med 320:881–886
Thivolet C, Beaufrère B, Gebuhrer L, Chatelain P, Orgiazzi J, François R (1991) Autoantibodies and genetic factors associated with the development of type 1 (insulin-dependent) diabetes mellitus in first degree relatives of diabetic patients. Diabetologia 34:186–191
McEvoy RC, Witt ME, Ginsberg-Fellner F, Rubinstein P (1986) Anti-insulin antibodies in children with type 1 diabetes mellitus: genetic regulation of production and presence at diagnosis before insulin replacement. Diabetes 35:634–641
Vardi P, Crisa L, Jackson RA et al. (1991) Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type 1 (insulin-dependent) diabetic patients. Diabetologia 34:93–102
Chase HP, Voss MA, Butter-Simon N, Hoops S, O'Brien D, Dobersen MJ (1987) Diagnosis of pre-type 1 diabetes. J Pediatr 111: 807–812
Nerup J, Mandrup-Poulsen T, Molvig J, Helqvist S, Wogensen L, Egeberg J (1988) Mechanisms of pancreatic β-cell destruction in type 1 diabetes. Diabetes Care 11 [Suppl 1]: 16–23
Dahlquist G, Blom L, Tuvemo T, Nyström L, Sandström A, Wall S (1989) The Swedish childhood diabetes study — Results from a nine year case register and a one year case-referent study indicating that type 1 (insulin-dependent) diabetes mellitus is associated with both type 2 (non-insulin-dependent) diabetes mellitus and autoimmune disorders. Diabetologia 32:2–6
Knip M, Penttilä P, Karjalainen J, Lounamaa R, Åkerblom HK and the Study Group on Childhood Diabetes in Finland (1991) Clinical presentation and autoimmune markers in familial cases with IDDM (abstract). Diabetes 40 [Suppl 1]: 279 A
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Knip, M., Vähäsalo, P., Karjalainen, J. et al. Natural history of preclinical IDDM in high risk siblings. Diabetologia 37, 388–393 (1994). https://doi.org/10.1007/BF00408476
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00408476